Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

From the wind farms of Jutland to the rising skyline of NEOM, Denmark and Saudi Arabia are edging toward a new phase in their ...

President Trump’s threat to impose 30% tariffs on the European Union disrupted negotiations. From cars to wine, these are the industries on the line.

A plan to acquire and operate what is expected to become the world’s most powerful commercial quantum computer has been ...

Trump’s budget proposal, from May, seeks to slash the Department of Health and Human Services’ budget by $31.3 billion ...

Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...

As the global obesity medication market skyrockets, South Korean pharmaceuticals are rushing to develop national obesity ...

Large study shows that most cases of depression or schizophrenia occur in people without relatives diagnosed with the same ...

A recent spot check revealed that drugstores in Nairobi, including online pharmacies, are selling more insulin than in ...

The Novo Nordisk Foundation and the Danish State Loan Fund announced on Thursday that they are investing in the world's most ...